If you've passed UKMLA, PLAB, or MRCGP, the clinical knowledge tested in the MCCQE1 will feel broadly familiar. It's a generalist medical knowledge exam covering the same clinical territory: diagnosis, investigation, management, and clinical reasoning across all major specialties.
The traps are in the details — and they're the details UK doctors don't expect.
Format comparison
MCCQE1: Approximately 210 MCQs, computer-based, single-day exam. Previously included Clinical Decision Making (CDM) cases, but these were removed in the 2025 update. Now entirely MCQ format. Pass rate for IMGs from approved jurisdictions (including the UK): approximately 70–80%.
UKMLA AKT: Similar format — SBA MCQs testing clinical knowledge. Aligned to NICE/CKS/BNF guidelines.
PLAB 1: 180 SBAs testing UK clinical standards. Similar breadth to MCCQE1 but explicitly UK-referenced.
The overlap: Approximately 70–80% of the clinical reasoning is identical. The pathophysiology of pneumonia doesn't change at the border. The management principles for diabetes are broadly similar. The investigations you'd order for chest pain are the same.
The 20–30% that's different: This is what catches UK-trained doctors.
What's different: guidelines
Screening recommendations. The Canadian Task Force on Preventive Health Care (CTFPHC) differs from the UK National Screening Committee and NICE on several key topics:
Cervical screening: Canada recommends starting at age 25 (not 25 in the UK too, but the interval and method may differ — primary HPV testing is being rolled out variably across provinces). Colorectal screening: FIT-based in both countries, but the age ranges and intervals differ. Breast screening: Similar age ranges but different evidence interpretation and frequency in some provinces. Prostate screening: CTFPHC generally recommends against routine PSA screening — stronger than NICE's shared-decision-making position.
Hypertension management. Hypertension Canada guidelines differ from NICE NG136 in thresholds and first-line agents. The "A/C/D" algorithm that UK GPs know doesn't directly translate. Canadian guidelines use different target BPs for different populations.
Diabetes management. Diabetes Canada guidelines align broadly with NICE but diverge on some SGLT2 inhibitor indications, insulin initiation thresholds, and cardiovascular risk management integration.
Antimicrobial prescribing. Drug names, resistance patterns, and first-line choices differ. "Co-amoxiclav" (UK) = "amoxicillin-clavulanate" (Canada). "Flucloxacillin" (UK standard for cellulitis) is less commonly used in Canada — cephalexin or cloxacillin are typical first-line. If a MCCQE1 question asks for first-line cellulitis antibiotic and you answer flucloxacillin, you may be wrong.
What's different: drug names
Canadian prescribing uses generic drug names (like the UK) but some brand names differ, and some drugs available in the UK aren't available in Canada (and vice versa). Key differences:
"Paracetamol" (UK) = "acetaminophen" (Canada). You will see "acetaminophen" in MCCQE1 questions.
"Adrenaline" (UK) = "epinephrine" (Canada). Same drug, different name.
"Salbutamol" (UK) is the same in Canada, but the delivery devices and brand names differ.
Some UK-standard drugs (e.g., certain formulations of co-codamol, certain combined preparations) may not be available or standard in Canada.
How to prepare
Use a Canadian qbank as your primary resource. iatroX's Canadian qbank, CanadaQBank, and Toronto Notes-aligned questions will expose you to the Canadian guideline framework and drug naming conventions. Don't rely solely on UK resources.
Read Toronto Notes. This is the Canadian equivalent of the Oxford Handbook of Clinical Medicine — and it's the unofficial bible for MCCQE1 preparation. It uses Canadian guidelines, Canadian drug names, and Canadian clinical scenarios. If you read one resource, read this.
Build a "UK vs Canada" divergence list. As you study, note every instance where Canadian guidance differs from what you know. Screening thresholds, drug choices, investigation preferences, and management pathways. Keep this list and review it before the exam.
Don't over-prepare. If you've passed UKMLA or MRCGP, your clinical knowledge base is strong. The MCCQE1 is not harder than UK postgraduate exams — it's different. Focus your preparation on the Canadian-specific content, not on re-learning the medicine you already know.
Timeline: 6–10 weeks of focused preparation for a UK-trained GP. 40–60 questions per day using Canadian resources, plus Toronto Notes for reference. The doctors who fail MCCQE1 as UK graduates are typically those who assumed their UK knowledge was sufficient without Canadian-specific revision.
iatroX offers a dedicated MCCQE1 qbank with Canadian guideline-referenced explanations and adaptive difficulty. AI clinical search for real-time guideline queries. Built by a practising NHS GP.